Sequential percutaneous mitral valve repair and transapical aortic valve implantation successfully treated severe mitral and aortic regurgitation in a high surgical risk patient.
Case Report (n=1)
No
Does sequential percutaneous intervention (MitraClip followed by transapical TAVI) improve symptoms and valvular function in a high-surgical-risk patient with severe mitral and pure aortic regurgitation?
Sequential percutaneous intervention with MitraClip and transapical TAVI is feasible and can improve symptoms in high-surgical-risk patients with severe mitral and pure aortic regurgitation.
Percutaneous approach for valvular heart disease is accepted as a safe and feasible strategy to treat patients considered at high surgical risk with aortic stenosis and mitral regurgitation. Additionally, the growing experience led to the increasing use of transcatheter aortic valve implantation in several indications, such as in pure aortic regurgitation. The authors present the case of a 72-year-old woman with prohibitive surgical risk due to several comorbidities, including a chronic arterial dissection from the right carotid artery to the femoral arteries bilaterally that presented with signs and symptoms of heart failure, having a transthoracic echocardiography that showed severe functional mitral and aortic regurgitation. Combined percutaneous intervention for multivalvular disease in this clinical scenario is challenging, and the reported experience is still scarce and limited to inoperable patients.
Guerreiro et al. (Fri,) conducted a case report in Severe mitral and aortic regurgitation (n=1). Sequential percutaneous mitral valve repair (MitraClip) and transapical aortic valve implantation (Symetis ACURATE TA) was evaluated. Sequential percutaneous mitral valve repair and transapical aortic valve implantation successfully treated severe mitral and aortic regurgitation in a high surgical risk patient.